COX-2 as the key target of LianXia NingXin Formula for treating Sympathetic Remodeling after Myocardial Infarction: pharmacological network prediction with experimental validation

Yang Yang, Fangyuan Dai, Xin Ma, Xue Yu, Xuezhong Zhou, Ping Li. COX-2 as the key target of LianXia NingXin Formula for treating Sympathetic Remodeling after Myocardial Infarction: pharmacological network prediction with experimental validation. In Yufei Huang, Lukasz A. Kurgan, Feng Luo, Xiaohua Hu, Yidong Chen, Edward R. Dougherty, Andrzej Kloczkowski, Yaohang Li, editors, IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2021, Houston, TX, USA, December 9-12, 2021. pages 3898-3905, IEEE, 2021. [doi]

Abstract

Abstract is missing.